In the field of life medicine, Chengzhi Group closely follows the forefront of synthetic biology research and focuses on the human health industry. In the field of D-ribose subdivision, Chengzhi has c
In the field of synthetic biology, the company will continue to explore the D-ribose market and expand its market share. The company will strive to increase the market share of D-ribose terminal produ
D-Mannose is a monosaccharide with a structure similar to glucose, involved in numerous metabolic processes, and is the only glyconutrient used clinically. It is widely distributed in body fluids and
One of the synthesis methods of D-mannose in the field of biotechnology is to use mannitol as raw material and synthesize D-mannose through enzymatic catalysis. Specifically, it includes: using mannit
On November 19, 2024, under the leadership of the Municipal Ocean Shipping Association, Liangzhilong Caishibang visited the production line of Fudan Company. Our chairman Xu Zhoubo accompanied the exp
As the food and beverage industry continues to respond to growing demand for lower-calorie and healthier sugar alternatives, D-allulose is attracting increasing attention as a next-generation function
On November 19, 2024, under the auspices of the City Oceanic Association, Liangzhi Long and Caishi Bang visited Fudan Company to see the corporate production line. Our company's chairman, Xu Zhoubo, a
The global health and wellness sector is shifting as traditional zero-calorie sweeteners face scrutiny and consumers demand modern sugar substitutes. According to clinical insights from the Mayo Clini
A professional food manufacturer specializing in Soy processing has announced the upgrade of its production workshop to boost output of high-quality Tofu and Bean products. The company focuses on stan